Literature DB >> 2766077

Extraosseous Ewing's sarcoma. Computed tomography evaluation before and after chemotherapy.

A Shirkhoda1, M Peuchot.   

Abstract

Fourteen patients with extraosseous Ewing's sarcoma were evaluated by computed tomography (CT) and conventional radiography. The sites of involvement were in the lower extremities (six cases), the chest wall (four), pelvis (two), and the paravertebral region (two). In seven cases, the initial contrast-enhanced CT disclosed a necrotic soft tissue mass in four, two of them with peripheral enhancement. In three cases, the mass was homogeneous and did not enhance. CT enabled us to detect the size of the mass, the integrity of adjacent bone and medullary cavity, and to determine the presence or absence of metastases. CT was useful for evaluation of the patients' tumor response to treatment. In three of four patients treated with chemotherapy, CT showed evidence of a dramatic initial response. In one patient who was resistant to chemotherapy, surgical methods were required.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766077     DOI: 10.1016/0899-7071(89)90097-1

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

1.  Extraosseous Ewing sarcoma of the thyroid gland.

Authors:  Pavani Adapa; Tae-Woong Chung; Edwina J Popek; Jill V Hunter
Journal:  Pediatr Radiol       Date:  2009-08-19

Review 2.  Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management.

Authors:  George Galyfos; Georgios A Karantzikos; Nikolaos Kavouras; Argiri Sianou; Konstantinos Palogos; Konstantinos Filis
Journal:  Indian J Surg       Date:  2015-11-13       Impact factor: 0.656

3.  Extraosseus Ewing sarcoma: An uncommon periclavicular location.

Authors:  Fabrizio Albarello; Giulia Deriu; Stefania Goletti; Paolo Campioni
Journal:  Radiol Case Rep       Date:  2016-02-17

4.  Extraskeletal Ewing sarcoma of the abdominal wall.

Authors:  A Askri; L Ben Farhat; B Ghariani; A Rabeh; N Dali; W Said; L Hendaoui
Journal:  Cancer Imaging       Date:  2008-09-10       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.